FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

933240711000036108: linagliptin (AU substance)

Status: current, Primitive. Date: 29-Feb 2012. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
980159171000036118 linagliptin (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
980159181000036116 linagliptin en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
linagliptin Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trajenta 5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 760068646
Trajentamet 2.5 mg/500 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 841267872
Trajentamet 2.5 mg/1000 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 1024123060
linagliptin has intended active ingredient True linagliptin Inferred relationship Some 1
linagliptin 5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 1746236998
linagliptin 5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 1746236998
Trajentamet 2.5 mg/850 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 2059206100
Trajentamet 2.5 mg/500 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 841267872
linagliptin + metformin has intended active ingredient True linagliptin Inferred relationship Some 2
linagliptin 2.5 mg + metformin hydrochloride 500 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 608969114
linagliptin 2.5 mg + metformin hydrochloride 500 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 608969114
linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 1618352988
linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 1618352988
linagliptin 2.5 mg + metformin hydrochloride 1 g tablet has intended active ingredient True linagliptin Inferred relationship Some 1987083048
linagliptin 2.5 mg + metformin hydrochloride 1 g tablet has Australian BoSS True linagliptin Inferred relationship Some 1987083048
Trajenta 5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 760068646
Trajentamet 2.5 mg/850 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 2059206100
Trajentamet 2.5 mg/1000 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 1024123060
empagliflozin + linagliptin has intended active ingredient True linagliptin Inferred relationship Some 1
empagliflozin 10 mg + linagliptin 5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 805921526
empagliflozin 10 mg + linagliptin 5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 805921526
Glyxambi 10 mg/5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 1539795838
Glyxambi 10 mg/5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 1539795838
empagliflozin 25 mg + linagliptin 5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 234937204
empagliflozin 25 mg + linagliptin 5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 234937204
Glyxambi 25 mg/5 mg tablet has Australian BoSS True linagliptin Inferred relationship Some 602535016
Glyxambi 25 mg/5 mg tablet has intended active ingredient True linagliptin Inferred relationship Some 602535016

This concept is not in any reference sets

Back to Start